Anfield Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94K | Hold |
85
| – | – | ﹤0.01% | 392 |
|
|
2025
Q1 | $5.18K | Hold |
85
| – | – | ﹤0.01% | 318 |
|
|
2024
Q4 | $4.81K | Sell |
85
-75
| -47% | -$4.24K | ﹤0.01% | 319 |
|
|
2024
Q3 | $8.28K | Buy |
160
+75
| +88% | +$3.88K | ﹤0.01% | 257 |
|
|
2024
Q2 | $3.53K | Buy |
+85
| New | +$3.53K | ﹤0.01% | 292 |
|
|
2020
Q1 | – | Sell |
-100
| Closed | -$7K | – | 143 |
|
|
2019
Q4 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 346 |
|